Cargando…
Gentransfer mit adenoviralen Vektoren
Adenoviral vectors are promising vectors for somatic gene therapy in a number of inherited and acquired disorders. In this contribution, the current scientific knowledge as it relates to production and function of adenoviral vectors is summarized. The different types of adenoviral vectors are descri...
Autor principal: | |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer-Verlag
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095895/ http://dx.doi.org/10.1007/s00103-001-0292-0 |
_version_ | 1783510707514376192 |
---|---|
author | Kochanek, S. |
author_facet | Kochanek, S. |
author_sort | Kochanek, S. |
collection | PubMed |
description | Adenoviral vectors are promising vectors for somatic gene therapy in a number of inherited and acquired disorders. In this contribution, the current scientific knowledge as it relates to production and function of adenoviral vectors is summarized. The different types of adenoviral vectors are described and their respective advantages and disadvantages are delineated. Current problems with adenoviral vectors, and implications as they derive from the fatality observed in the Philadelphia gene therapy trial are discussed. |
format | Online Article Text |
id | pubmed-7095895 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Springer-Verlag |
record_format | MEDLINE/PubMed |
spelling | pubmed-70958952020-03-26 Gentransfer mit adenoviralen Vektoren Kochanek, S. Bundesgesundheitsblatt Gesundheitsforschung Gesundheitsschutz Leitthema: Gentherapie: Forschung, Entwicklung und Regularien Adenoviral vectors are promising vectors for somatic gene therapy in a number of inherited and acquired disorders. In this contribution, the current scientific knowledge as it relates to production and function of adenoviral vectors is summarized. The different types of adenoviral vectors are described and their respective advantages and disadvantages are delineated. Current problems with adenoviral vectors, and implications as they derive from the fatality observed in the Philadelphia gene therapy trial are discussed. Springer-Verlag 2001 /pmc/articles/PMC7095895/ http://dx.doi.org/10.1007/s00103-001-0292-0 Text en © Springer-Verlag Berlin Heidelberg 2001 This article is made available via the PMC Open Access Subset for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. |
spellingShingle | Leitthema: Gentherapie: Forschung, Entwicklung und Regularien Kochanek, S. Gentransfer mit adenoviralen Vektoren |
title | Gentransfer mit adenoviralen Vektoren |
title_full | Gentransfer mit adenoviralen Vektoren |
title_fullStr | Gentransfer mit adenoviralen Vektoren |
title_full_unstemmed | Gentransfer mit adenoviralen Vektoren |
title_short | Gentransfer mit adenoviralen Vektoren |
title_sort | gentransfer mit adenoviralen vektoren |
topic | Leitthema: Gentherapie: Forschung, Entwicklung und Regularien |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7095895/ http://dx.doi.org/10.1007/s00103-001-0292-0 |
work_keys_str_mv | AT kochaneks gentransfermitadenoviralenvektoren |